SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001096906-22-000524
Filing Date
2022-03-09
Accepted
2022-03-09 16:37:53
Documents
15
Period of Report
2022-03-07
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING axim-20220307.htm   iXBRL 8-K 17416
2 PRESS RELEASE axim_ex99z1.htm EX-99.1 12216
7 IMAGE axim8k_1.jpg GRAPHIC 4297
  Complete submission text file 0001096906-22-000524.txt   198641

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axim-20220307_def.xml EX-101.DEF 2175
4 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT axim-20220307_lab.xml EX-101.LAB 20884
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axim-20220307_pre.xml EX-101.PRE 13914
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axim-20220307.xsd EX-101.SCH 21877
9 EXTRACTED XBRL INSTANCE DOCUMENT axim-20220307_htm.xml XML 2446
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54296 | Film No.: 22725873
SIC: 2834 Pharmaceutical Preparations